226 related articles for article (PubMed ID: 24040299)
1. Opsonising antibodies to P. falciparum merozoites associated with immunity to clinical malaria.
Hill DL; Eriksson EM; Li Wai Suen CS; Chiu CY; Ryg-Cornejo V; Robinson LJ; Siba PM; Mueller I; Hansen DS; Schofield L
PLoS One; 2013; 8(9):e74627. PubMed ID: 24040299
[TBL] [Abstract][Full Text] [Related]
2. Efficient measurement of opsonising antibodies to Plasmodium falciparum merozoites.
Hill DL; Eriksson EM; Carmagnac AB; Wilson DW; Cowman AF; Hansen DS; Schofield L
PLoS One; 2012; 7(12):e51692. PubMed ID: 23300556
[TBL] [Abstract][Full Text] [Related]
3. Merozoite Antigens of Plasmodium falciparum Elicit Strain-Transcending Opsonizing Immunity.
Hill DL; Wilson DW; Sampaio NG; Eriksson EM; Ryg-Cornejo V; Harrison GLA; Uboldi AD; Robinson LJ; Beeson JG; Siba P; Cowman AF; Hansen DS; Mueller I; Schofield L
Infect Immun; 2016 Aug; 84(8):2175-2184. PubMed ID: 27185785
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.
Stanisic DI; Richards JS; McCallum FJ; Michon P; King CL; Schoepflin S; Gilson PR; Murphy VJ; Anders RF; Mueller I; Beeson JG
Infect Immun; 2009 Mar; 77(3):1165-74. PubMed ID: 19139189
[TBL] [Abstract][Full Text] [Related]
5. The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria.
Reiling L; Richards JS; Fowkes FJ; Wilson DW; Chokejindachai W; Barry AE; Tham WH; Stubbs J; Langer C; Donelson J; Michon P; Tavul L; Crabb BS; Siba PM; Cowman AF; Mueller I; Beeson JG
PLoS One; 2012; 7(9):e45253. PubMed ID: 23028883
[TBL] [Abstract][Full Text] [Related]
6. Patterns of protective associations differ for antibodies to P. falciparum-infected erythrocytes and merozoites in immunity against malaria in children.
Chan JA; Stanisic DI; Duffy MF; Robinson LJ; Lin E; Kazura JW; King CL; Siba PM; Fowkes FJ; Mueller I; Beeson JG
Eur J Immunol; 2017 Dec; 47(12):2124-2136. PubMed ID: 28833064
[TBL] [Abstract][Full Text] [Related]
7. Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia.
Richards JS; Stanisic DI; Fowkes FJ; Tavul L; Dabod E; Thompson JK; Kumar S; Chitnis CE; Narum DL; Michon P; Siba PM; Cowman AF; Mueller I; Beeson JG
Clin Infect Dis; 2010 Oct; 51(8):e50-60. PubMed ID: 20843207
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity.
al-Yaman F; Genton B; Kramer KJ; Chang SP; Hui GS; Baisor M; Alpers MP
Am J Trop Med Hyg; 1996 May; 54(5):443-8. PubMed ID: 8644896
[TBL] [Abstract][Full Text] [Related]
9. Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria.
Osier FH; Feng G; Boyle MJ; Langer C; Zhou J; Richards JS; McCallum FJ; Reiling L; Jaworowski A; Anders RF; Marsh K; Beeson JG
BMC Med; 2014 Jul; 12():108. PubMed ID: 24980799
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium falciparum MSP3 Exists in a Complex on the Merozoite Surface and Generates Antibody Response during Natural Infection.
Deshmukh A; Chourasia BK; Mehrotra S; Kana IH; Paul G; Panda A; Kaur I; Singh SK; Rathore S; Das A; Gupta P; Kalamuddin M; Gakhar SK; Mohmmed A; Theisen M; Malhotra P
Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29760216
[No Abstract] [Full Text] [Related]
11. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
[TBL] [Abstract][Full Text] [Related]
12. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
Jäschke A; Coulibaly B; Remarque EJ; Bujard H; Epp C
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877929
[TBL] [Abstract][Full Text] [Related]
13. Cytophilic Antibodies Against Key Plasmodium falciparum Blood Stage Antigens Contribute to Protection Against Clinical Malaria in a High Transmission Region of Eastern India.
Kana IH; Garcia-Senosiain A; Singh SK; Tiendrebeogo RW; Chourasia BK; Malhotra P; Sharma SK; Das MK; Singh S; Adu B; Theisen M
J Infect Dis; 2018 Aug; 218(6):956-965. PubMed ID: 29733355
[TBL] [Abstract][Full Text] [Related]
14. Breadth of Functional Antibodies Is Associated With Plasmodium falciparum Merozoite Phagocytosis and Protection Against Febrile Malaria.
Kana IH; Singh SK; Garcia-Senosiain A; Dodoo D; Singh S; Adu B; Theisen M
J Infect Dis; 2019 Jun; 220(2):275-284. PubMed ID: 30820557
[TBL] [Abstract][Full Text] [Related]
15. High yield purification of Plasmodium falciparum merozoites for use in opsonizing antibody assays.
Hill DL; Eriksson EM; Schofield L
J Vis Exp; 2014 Jul; (89):. PubMed ID: 25078358
[TBL] [Abstract][Full Text] [Related]
16. The association between naturally acquired IgG subclass specific antibodies to the PfRH5 invasion complex and protection from Plasmodium falciparum malaria.
Weaver R; Reiling L; Feng G; Drew DR; Mueller I; Siba PM; Tsuboi T; Richards JS; Fowkes FJI; Beeson JG
Sci Rep; 2016 Sep; 6():33094. PubMed ID: 27604417
[TBL] [Abstract][Full Text] [Related]
17. Antibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adults.
Dent AE; Bergmann-Leitner ES; Wilson DW; Tisch DJ; Kimmel R; Vulule J; Sumba PO; Beeson JG; Angov E; Moormann AM; Kazura JW
PLoS One; 2008; 3(10):e3557. PubMed ID: 18958285
[TBL] [Abstract][Full Text] [Related]
18. Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response.
Stanisic DI; Fowkes FJ; Koinari M; Javati S; Lin E; Kiniboro B; Richards JS; Robinson LJ; Schofield L; Kazura JW; King CL; Zimmerman P; Felger I; Siba PM; Mueller I; Beeson JG
Infect Immun; 2015 Feb; 83(2):646-60. PubMed ID: 25422270
[TBL] [Abstract][Full Text] [Related]
19. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort.
Adamou R; Dechavanne C; Sadissou I; d'Almeida T; Bouraima A; Sonon P; Amoussa R; Cottrell G; Le Port A; Theisen M; Remarque EJ; Longacre S; Moutairou K; Massougbodji A; Luty AJF; Nuel G; Migot-Nabias F; Sanni A; Garcia A; Milet J; Courtin D
Malar J; 2019 Jun; 18(1):194. PubMed ID: 31185998
[TBL] [Abstract][Full Text] [Related]
20. Microscopic and Submicroscopic Asymptomatic Plasmodium falciparum Infections in Ghanaian Children and Protection against Febrile Malaria.
Adu B; Issahaque QA; Sarkodie-Addo T; Kumordjie S; Kyei-Baafour E; Sinclear CK; Eyia-Ampah S; Owusu-Yeboa E; Theisen M; Dodoo D
Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32719157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
